Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
7536807
Reference Type
Journal Article
Subtype
Review
Title
Corneal toxicity induced by vesicating agents and effective treatment options
Author(s)
Goswami, DG; Tewari-Singh, N; Agarwal, R
Year
2016
Is Peer Reviewed?
Yes
Journal
Annals of the New York Academy of Sciences
ISSN:
0077-8923
EISSN:
1749-6632
Publisher
BLACKWELL SCIENCE PUBL
Location
OXFORD
Book Title
COUNTERMEASURES AGAINST CHEMICAL THREATS
Volume
1374
Issue
1
Page Numbers
193-201
Language
English
PMID
27327041
DOI
10.1111/nyas.13121
Web of Science Id
WOS:000379428500022
Abstract
The vesicating agents sulfur mustard (SM) and lewisite (LEW) are potent chemical warfare agents that primarily cause damage to the ocular, skin, and respiratory systems. However, ocular tissue is the most sensitive organ, and vesicant exposure results in a biphasic injury response, including photophobia, corneal lesions, corneal edema, ulceration, and neovascularization, and may cause loss of vision. There are several reports on ocular injury from exposure to SM, which has been frequently used in warfare. However, there are very few reports on ocular injury by LEW, which indicate that injury symptoms appear instantly after exposure and faster than SM. In spite of extensive research efforts, effective therapies for vesicant-induced ocular injuries, mainly to the most affected corneal tissue, are not available. Hence, we have established primary human corneal epithelial cells and rabbit corneal organ culture models with the SM analog nitrogen mustard, which have helped to test the efficacy of potential therapeutic agents. These agents will then be further evaluated against in vivo SM- and LEW-induced corneal injury models, which will assist in the development of potential broad-spectrum therapies against vesicant-induced ocular injuries.
Editor(s)
Laskin, JD;
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity